Cingulate Inc.

Cingulate Chairman and CEO Shane J. Schaffer LIVE in studio with the Big Biz Show crew. A big shout-out to Sully and the gang for their amazing hospitality and continued interest in Cingulate’s mission to fulfill the unmet needs in ADHD and other CNS disorders. Check out?https://www.cingulate.com?for all the latest updates!? #cingulate #adhd #cing #adhdawareness https://lnkd.in/gEFyb8xT

Shane Schaffer, CEO of Cingulate Inc, recently rejoined The Big Biz Show crew to discuss some exciting upcoming company milestones! ?? We dove into Cingulate's innovative ADHD treatment solutions and also discussed Cingulate's proprietary drug delivery platform, which aims to improve the precision and timing of medication delivery for better patient outcomes. ?? A big thank you to The Big Biz Show crew for hosting! Want to learn more about the advancements we discussed? Check out https://www.cingulate.com for all the latest updates! ?? #TheBigBizShow #cing #Cingulate #adhd #adhdawareness #nasdaq https://lnkd.in/gTiV5TKZ

Cingulate's CEO, Shane Schaffer, recently rejoined the cast of the?Big Biz Show.???? Tune in to hear him further discuss Cingulate’s pipeline, groundbreaking ADHD treatment, CTx-1301, and its innovative Precision Timed Release? (PTR?) technology. ?? Watch now: https://lnkd.in/gE2qjzhe #Cingulate #BigBizShow #PharmaInnovation #ADHD #adhd #adhdawareness #CING #Nasdaq #adhdawarenessmonth

#ICYMI Cingulate’s Shane Schaffer recently joined the cast of nationally syndicated Big Biz Show. #adhd #adhdawareness #CING #Nasdaq #adhdawarenessmonth #Cingulate https://lnkd.in/dzGKV2HG

October is ADHD Awareness Month! The 2024 ADHD Awareness Month theme is "Awareness is Key!" Cingulate is proud to be working to bring new therapies to improve the lives of patients and providers. #APSARD #CADDAC #ADHDAwareness #ADHD #CHADD #CING #ADHDCoaches #ADDA https://lnkd.in/gA86FYy https://lnkd.in/erSqgWxu https://add.org/

We're proud to announce that Cingulate Inc. has been named a 2024 Top Drug Delivery Solutions Provider by Medtech Business Review. #ICYMI Cingulate Inc.'s Naama Courtemanche & Nicholas Myslinski wrote about our proprietary PTR??technology last month. https://lnkd.in/ezTTMxeR

#ICYMI Cingulate's CEO, Shane Schaffer, discusses our disruptive PTR drug delivery technology and the future of ADHD medicine. #adhd #cingulate #cing #Nasdaq #adhdawareness https://lnkd.in/g8XMs3Zk

#ICYMI Cingulate's CEO, Shane Schaffer, appeared live this morning on Benzinga All Access to discuss our recently issued European patent, the state of the ADHD marketplace and the potential expansion of our PTR? platform. #ADHD #NASDAQ #adhdawareness #CING #Cingulate https://lnkd.in/gCMYpHtJ

Check out our latest interview with Kyle Livingston from OTB Capital discussing Cingulate’s recent EU patent and the impressive market response. #ADHD #CING #ADHDAwareness #NASDAQ https://lnkd.in/guwQTg3E

Cingulate is leading the way with their cutting-edge Precision Timed Release? (PTR?) platform technology, making these innovative concepts a reality. #CING #ADHD #PTR #Cingulate #ADHDawareness www.cingulate.com https://lnkd.in/ezTTMxeR